Literature DB >> 26521062

Diffuse invasive breast carcinoma of no special type.

Tibor Tot1.   

Abstract

Diffuse invasive breast carcinomas are rare tumors associated with unfavorable prognostic parameters. This growth pattern is often related to invasive lobular cancer (ILC). Diffuse ductal breast carcinoma of no special type (NST) is largely under-recognized in the literature. We identified 70 diffuse invasive breast carcinomas in a consecutive series of 1249 invasive tumors. Based on morphology and E-cadherin expression, 15/70 were NST and 55/70 were ILC. Subgroups differed in mammographic appearance, as more NST tumors than ILCs formed stellate masses (53 vs. 18 %, p = 0.000436) while ILCs displayed more architectural distortion. NST tumors were significantly more often radiologically extensive than ILCs (80 vs. 38 %, p = 0.0042987). Subgroups did not differ significantly in disease extent on histology, lymph node status, progesterone receptor status, and molecular phenotype, with a difference of borderline statistical significance in estrogen receptor status (87 vs. 100 %, p = 0.0434783). Significantly more NST tumors were HER2 positive (27 vs. 4 %, p = 0.0050463) and showed high Ki67 proliferation index (60 vs. 25 %, p = 0.0121808). The most striking differences occurred in the histology grade of the in situ (high grade in 53 vs. 4 %) and invasive (high grade in 27 vs. 2 %) tumor components and in the distribution of the in situ component (diffuse in 73 vs. 11 %). We conclude that diffuse invasive breast carcinomas of NST comprise a small subgroup of breast carcinomas. Most of these cancers are non-high grade and of luminal phenotype, but extensive and lymph node positive with worse prognostic parameters than diffuse ILC.

Entities:  

Keywords:  Breast; Breast cancer of no special type; Diffuse invasive cancer; Invasive lobular cancer; Large-format histology; Subgross morphology

Mesh:

Substances:

Year:  2015        PMID: 26521062     DOI: 10.1007/s00428-015-1873-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Axillary lymph node status in unifocal, multifocal, and diffuse breast carcinomas: differences are related to macrometastatic disease.

Authors:  Tibor Tot
Journal:  Ann Surg Oncol       Date:  2012-04-03       Impact factor: 5.344

2.  Breast cancer multifocality, disease extent, and survival.

Authors:  Tibor Tot; Mária Gere; Gyula Pekár; Miklós Tarján; Syster Hofmeyer; Dan Hellberg; David Lindquist; Tony Hsiu-His Chen; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; László Tabár
Journal:  Hum Pathol       Date:  2011-06-12       Impact factor: 3.466

3.  Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.

Authors:  Ulrich Brinck; Susanne Jacobs; Michael Neuss; Kalman Tory; Werner Rath; Bettina Kulle; Laszlo Füzesi
Journal:  Anticancer Res       Date:  2004 Jul-Aug       Impact factor: 2.480

4.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

5.  Molecular phenotypes of unifocal, multifocal, and diffuse invasive breast carcinomas.

Authors:  Tibor Tot; Gyula Pekár; Syster Hofmeyer; Maria Gere; Miklós Tarján; Dan Hellberg; David Lindquist
Journal:  Patholog Res Int       Date:  2010-11-03

6.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

7.  Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.

Authors:  Tibor Tot
Journal:  Cancer       Date:  2007-12-01       Impact factor: 6.860

8.  A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Authors:  Hiroaki Nitta; Brian D Kelly; Mary Padilla; Nikolaus Wick; Patrick Brunhoeber; Isaac Bai; Shalini Singh; Jim Ranger-Moore; Chris Bieniarz; Hitoshi Tsuda; Thomas M Grogan
Journal:  Diagn Pathol       Date:  2012-05-30       Impact factor: 2.644

9.  The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases.

Authors:  Tibor Tot
Journal:  Int J Breast Cancer       Date:  2012-10-21

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

View more
  3 in total

Review 1.  The new TNM-based staging of breast cancer.

Authors:  Gábor Cserni; Ewa Chmielik; Bálint Cserni; Tibor Tot
Journal:  Virchows Arch       Date:  2018-01-27       Impact factor: 4.064

2.  The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides.

Authors:  Tibor Tot; Maria Gere; Syster Hofmeyer; Annette Bauer; Ulrika Pellas
Journal:  Virchows Arch       Date:  2019-08-13       Impact factor: 4.064

3.  Delayed presentation of inflammatory breast carcinoma during the COVID-19 pandemic.

Authors:  Daniele Bernardi; Emanuele Asti; Giulia Bonavina; Alberto Luporini; Claudio Clemente; Luigi Bonavina
Journal:  Eur Surg       Date:  2021-06-15       Impact factor: 0.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.